PL369338A1 - Ophthalmologic treatment methods using selective inos inhibitors - Google Patents

Ophthalmologic treatment methods using selective inos inhibitors

Info

Publication number
PL369338A1
PL369338A1 PL02369338A PL36933802A PL369338A1 PL 369338 A1 PL369338 A1 PL 369338A1 PL 02369338 A PL02369338 A PL 02369338A PL 36933802 A PL36933802 A PL 36933802A PL 369338 A1 PL369338 A1 PL 369338A1
Authority
PL
Poland
Prior art keywords
treatment methods
inos inhibitors
selective inos
ophthalmologic treatment
ophthalmologic
Prior art date
Application number
PL02369338A
Other languages
English (en)
Polish (pl)
Inventor
Pamela T. Manning
Jane R. Connor
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of PL369338A1 publication Critical patent/PL369338A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02369338A 2001-09-24 2002-09-24 Ophthalmologic treatment methods using selective inos inhibitors PL369338A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/961,816 US20030109522A1 (en) 2001-09-24 2001-09-24 Ophthalmologic treatment methods using selective iNOS inhibitors

Publications (1)

Publication Number Publication Date
PL369338A1 true PL369338A1 (en) 2005-04-18

Family

ID=25505060

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02369338A PL369338A1 (en) 2001-09-24 2002-09-24 Ophthalmologic treatment methods using selective inos inhibitors

Country Status (13)

Country Link
US (1) US20030109522A1 (enExample)
EP (1) EP1429777A4 (enExample)
JP (1) JP2005506986A (enExample)
KR (1) KR20040039393A (enExample)
CN (1) CN1556707A (enExample)
AU (1) AU2002327041A2 (enExample)
BR (1) BR0212991A (enExample)
CA (1) CA2455910A1 (enExample)
IL (1) IL161004A0 (enExample)
MX (1) MXPA04002711A (enExample)
PL (1) PL369338A1 (enExample)
WO (1) WO2003026668A1 (enExample)
ZA (1) ZA200402285B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143431A1 (en) * 2005-05-17 2010-01-13 Santen Pharmaceutical Co., Ltd. Protective agent for neurocyte comprising amidino derivative as active ingredient
ES2965961T3 (es) * 2016-03-07 2024-04-17 Centro Nac De Investigaciones Cardiovasculares Carlos Iii F S P Uso de inhibidores selectivos de INOS para el tratamiento de aneurismas de la aorta torácica (TAA) en un sujeto

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132453A (en) * 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
GB9811599D0 (en) * 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
PT1265860E (pt) * 2000-03-24 2005-10-31 Pharmacia Corp Compostos amidino uteis como inibidores de sintase de oxido nitrico
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa

Also Published As

Publication number Publication date
EP1429777A4 (en) 2005-06-22
EP1429777A1 (en) 2004-06-23
CN1556707A (zh) 2004-12-22
AU2002327041A2 (en) 2003-04-07
WO2003026668A1 (en) 2003-04-03
ZA200402285B (en) 2005-06-13
KR20040039393A (ko) 2004-05-10
MXPA04002711A (es) 2004-07-05
JP2005506986A (ja) 2005-03-10
US20030109522A1 (en) 2003-06-12
CA2455910A1 (en) 2003-04-03
IL161004A0 (en) 2004-08-31
BR0212991A (pt) 2004-08-17

Similar Documents

Publication Publication Date Title
EP1361604A4 (en) DEVICE AND METHOD OF TREATMENT
GB2393202B (en) Methods of well treatment
AU2036902A (en) Methods and apparatus for stroke patient treatment
AU4569801A (en) Device for glaucoma treatment and methods thereof
IL160754A0 (en) Dosage form, device and methods of treatment
GB0129976D0 (en) Treatment method
GB0118383D0 (en) Therapeutic methods
GB0108671D0 (en) Skin treatment
IL161005A0 (en) Neuroprotective treatment methods using selective inos inhibitors
GB0120147D0 (en) Treatment method
GB0124124D0 (en) Methods of treatment
IL156647A0 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
GB0112216D0 (en) Method of treatment
SG89379A1 (en) Treatment apparatus
GB0130763D0 (en) Treatment methods
GB0026838D0 (en) Treatment method
GB0008921D0 (en) Method of treatment
IL161004A0 (en) Ophthalmologic treatment methods using selective inos inhibitors
GB0118892D0 (en) Method of treatment
EP1303281A4 (en) METHODS OF TREATMENT
GB0104555D0 (en) New Therapeutic method
GB0126253D0 (en) Treatment method
HK1068248A (en) Neuroprotective treatment methods using selective inos inhibitors
GB0102927D0 (en) Treatment method
GB0013928D0 (en) Methods of treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)